These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results
Media

These Analysts Boost Their Forecasts On 10x Genomics After Q3 Results

Latest Ratings for TXG

Date Firm Action From To
Feb 2022 Citigroup Maintains Buy
Nov 2021 Morgan Stanley Maintains Overweight
Sep 2021 National Bank Of Canada Initiates Coverage On Sector Perform

View More Analyst Ratings for TXG

View the Latest Analyst Ratings

read more

​ 

This material is for informational purposes is not intended to be relied upon as a forecast, research or investment advice, and is not a recommendation, offer or solicitation to buy or sell any securities or to adopt any investment strategy. The opinions expressed are as of date of publication and are subject to change. Reliance upon information in this material is at the sole discretion of the reader. Past performance is not indicative of current or future results. This information provided is neither tax nor legal advice and investors should consult with their own advisors before making investment decisions. Investment involves risk including possible loss of principal.